Breast Biomarker Cytology Practice in 2023: Results of a College of American Pathologists Survey
This is the first survey from the CAP to investigate breast biomarker cytology practices. The findings reveal some differences among institution types and between domestic and international laboratories. These data provide a baseline for and support further studies and/or guidelines to promote and refine these practices.
Authors
- Deepu Alex (ORCID: https://orcid.org/0000-0001-6136-296X)
- Martin J. Magers (ORCID: https://orcid.org/0000-0001-8680-957X)
- Ann D. King (ORCID: https://orcid.org/0000-0002-5280-8349)
- Zaibo Li (ORCID: https://orcid.org/0000-0003-1325-1696)
- Sana Tabbara
- Poornima Hegde
- Rhona J. Souers
- Shahla Masood
- Janie Roberson
Institutions
- University of Connecticut (US)
- College of American Pathologists (US)
- LabCorp (United States) (US)
- Moffitt Cancer Center (US)
- University of Alabama at Birmingham (US)
- University of Florida (US)
- Jacksonville University (US)
- Ypsilanti District Library (US)
- IHA Hematology Oncology Consultants (US)
- Alexion Pharma (Switzerland) (CH)
- The Ohio State University (US)
- UConn Health (US)
- Florida College (US)
Publication Details
- Journal
- Archives of Pathology & Laboratory Medicine
- Published
- 2025-05-07
- DOI
- https://doi.org/10.5858/arpa.2025-0023-cp
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94